Atossa Therapeutics, Inc. (ATOS) Ownership

$1.01

north_east
$0.09 (9.78%)
Day's range
$0.92
Day's range
$1.05

Atossa Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 6.08 M $5.27 M   4.21% 4.71%
AMERIPRISE FINANCIAL INC 11/14/2025 2.95 M $2.56 M   -0.73% 2.29%
BLACKROCK, INC. 11/12/2025 2.00 M $1.73 M   -7.00% 1.55%
MILLENNIUM MANAGEMENT LLC 11/14/2025 1.67 M $1.45 M   -18.50% 1.29%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 1.55 M $1.34 M   -14.54% 1.20%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.36 M $1.18 M   4.76% 1.05%
STATE STREET CORP 11/14/2025 454.50 K $394.05 K   -12.02% 0.35%
GSA CAPITAL PARTNERS LLP 11/07/2025 310.75 K $269.00 K   508.98% 0.24%
NORTHERN TRUST CORP 11/14/2025 263.38 K $228.35 K   0.00% 0.20%
CITADEL ADVISORS LLC 11/14/2025 263.37 K $228.34 K   203.01% 0.20%
UBS GROUP AG 11/13/2025 260.72 K $226.05 K   -36.79% 0.20%
SQUAREPOINT OPS LLC 11/14/2025 253.34 K $219.65 K   39.89% 0.20%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 248.61 K $215.55 K   25.14% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 219.60 K $190.40 K   -19.83% 0.17%
GRAHAM CAPITAL MANAGEMENT, L.P. 11/14/2025 165.45 K $143.44 K   100.00% 0.13%
JANE STREET GROUP, LLC 11/14/2025 162.43 K $140.83 K   -64.59% 0.13%
BANK OF AMERICA CORP /DE/ 11/14/2025 155.17 K $134.53 K   55.79% 0.12%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 138.64 K $120.20 K   -66.70% 0.11%
MORGAN STANLEY 11/14/2025 112.35 K $97.41 K   -30.18% 0.09%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 97.29 K $82.00 K   100.00% 0.08%
MARSHALL WACE, LLP 11/13/2025 85.08 K $74.02 K   534.90% 0.07%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 80.00 K $69.36 K   0.00% 0.06%
COMMONWEALTH EQUITY SERVICES, LLC 10/22/2025 46.00 K $40.00 K   0.00% 0.04%
POINT72 ASIA (SINGAPORE) PTE. LTD. 11/14/2025 44.11 K $38.24 K   -50.00% 0.03%
JPMORGAN CHASE & CO 11/26/2025 38.22 K $33.13 K   1,294.20% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 37.10 K $32.28 K   3.63% 0.03%
CITADEL ADVISORS LLC 11/14/2025 33.70 K $29.22 K   21.66% 0.03%
GALLAGHER CAPITAL ADVISORS, LLC 11/06/2025 31.58 K $27.47 K   100.00% 0.02%
REGIONS FINANCIAL CORP 11/19/2025 30.00 K $26.01 K   0.00% 0.02%
LPL FINANCIAL LLC 11/12/2025 28.56 K $24.76 K   2.51% 0.02%
WOLVERINE TRADING, LLC 11/14/2025 28.00 K $24.44 K   -4.76% 0.02%
WOLVERINE TRADING, LLC 11/14/2025 27.30 K $23.83 K   100.00% 0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 27.00 K $23.49 K   100.00% 0.02%
CITADEL ADVISORS LLC 11/14/2025 25.20 K $21.85 K   98.43% 0.02%
XTX TOPCO LTD 11/14/2025 24.85 K $21.54 K   98.21% 0.02%
SIGMA PLANNING CORP 11/10/2025 24.00 K $20.81 K   100.00% 0.02%
PFG INVESTMENTS, LLC 10/31/2025 21.25 K $18.42 K   0.00% 0.02%
LVM CAPITAL MANAGEMENT LTD/MI 10/09/2025 21.00 K $18.00 K   0.00% 0.02%
WOLVERINE TRADING, LLC 11/14/2025 18.34 K $16.01 K   -2.23% 0.01%
HRT FINANCIAL LP 11/14/2025 16.93 K $14.00 K   -82.19% 0.01%
NORTHROCK PARTNERS, LLC 11/14/2025 16.75 K $14.52 K   0.00% 0.01%
JAIN GLOBAL LLC 11/14/2025 16.71 K $14.49 K   -86.42% 0.01%
DNB ASSET MANAGEMENT AS 11/12/2025 15.60 K $13.53 K   0.00% 0.01%
VICTORY CAPITAL MANAGEMENT INC 11/12/2025 14.86 K $12.89 K   -3.46% 0.01%
BANK OF NEW YORK MELLON CORP 11/03/2025 11.15 K $9.66 K   0.00% 0.01%
J. L. BAINBRIDGE & CO., INC. 10/17/2025 11.12 K $9.64 K   0.00% 0.01%
RAYMOND JAMES FINANCIAL INC 11/14/2025 10.82 K $9.38 K   -15.61% 0.01%
FOCUS FINANCIAL NETWORK, INC. 10/10/2025 10.15 K $8.80 K   0.00% 0.01%
JANNEY MONTGOMERY SCOTT LLC 10/27/2025 10.00 K $9.00 K   0.00% 0.01%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 8.85 K $7.36 K   0.00% 0.01%

Atossa Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 104 institutional investors and hedge funds held shares of Atossa Therapeutics, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 6.08 M

AMERIPRISE FINANCIAL INC: 2.95 M

BlackRock, Inc.: 2 M

MILLENNIUM MANAGEMENT LLC: 1.67 M

RENAISSANCE TECHNOLOGIES LLC: 1.55 M

GEODE CAPITAL MANAGEMENT, LLC: 1.36 M

15.00% of Atossa Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 28.86 M shares in the last 24 months. This purchase volume represents approximately $29.15 M in transactions.